Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry

Clinical trial NCT02427308 · WITHDRAWN

Trial details

NCT number: NCT02427308
Sponsor: Knight Therapeutics (USA) Inc
Status: WITHDRAWN
Study type: OBSERVATIONAL

Leishmaniasis or Other Uses of Miltefosine

Start date: 2015-07-01
Primary completion: 2025-03-28
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.